CHST2 Inhibitors

CHST2 inhibitors are a class of chemical compounds that target and inhibit the enzymatic activity of Carbohydrate Sulfotransferase 2 (CHST2), an enzyme responsible for the sulfation of glycosaminoglycans. CHST2 specifically catalyzes the transfer of sulfate groups to the N-acetylglucosamine residues within glycosaminoglycans, contributing to the biosynthesis of highly sulfated forms of heparan sulfate and chondroitin sulfate. These sulfated glycosaminoglycans are vital for the structure and function of proteoglycans, which are essential components of the extracellular matrix and play important roles in cell signaling, cell adhesion, and molecular recognition. Inhibition of CHST2 can, therefore, impact the sulfation pattern of glycosaminoglycans, altering their binding properties and interactions with other proteins and biomolecules.

The target protein, CHST2, is a member of the sulfotransferase family, which is involved in various biosynthetic pathways of glycosaminoglycans. This enzyme is localized primarily in the Golgi apparatus, where it modifies proteoglycans before they are transported to the cell surface or extracellular matrix. CHST2 plays a significant role in regulating the structural diversity of glycosaminoglycans, which in turn influences biological processes such as cell proliferation, migration, and matrix remodeling. Given its key role in modifying the extracellular environment, compounds that inhibit CHST2 can affect various cellular processes by altering the composition and functionality of the glycocalyx and proteoglycan interactions. Understanding the biochemical impact of CHST2 inhibition is critical for studying how glycosaminoglycan structure influences cellular behavior and extracellular communication.